HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING—
Price Investing Group
← Back to Research Watchlist
EW
Edwards Lifesciences Corp
Healthcare Medical Devices · California, USA · Reports in usd
—
Market Cap: $49.03B
Market Cap
$49.03B
Enterprise Val
$45.48B
P/E Ratio
48.79
P/B Ratio
4.62
Trailing PEG (1Y)
-1.85
As Of
Oct 1, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$10.72B
Gross Margin77.46%
Profit Margin77.46%
Return on Equity9.69%
Return on Assets7.42%
Current Ratio4.52
Debt/Equity0.07
LT Debt/Equity0.06
Revenue Per Share3.02

Income Statement

Jun 30, 2026
Revenue$1.74B
Cost of Revenue$392.4M
Gross Profit$1.35B
R&D$278.9M
SG&A$561.2M
Operating Expenses$875.4M
Operating Income$473.2M
Interest Expense$0.00
Tax Expense$278.4M
Net Income$241.9M
EPS (Basic)$0.42
EPS (Diluted)$0.42
EBIT$520.3M
EBITDA$569.6M
Consolidated Income$241.4M
Non-Controlling Interests-$500.0K

Balance Sheet

Jun 30, 2026
Cash & Equivalents$2.91B
Accounts Receivable$955.7M
Inventory$1.13B
Current Assets$6.82B
LT Investments$244.1M
Property, Plant & Equipment$1.94B
Intangibles$3.33B
Non-Current Assets$7.05B
Total Assets$13.87B
Accounts Payable$1.48B
Current Debt$24.1M
Current Liabilities$1.51B
LT Debt$680.3M
Non-Current Liabilities$1.63B
Total Liabilities$3.14B
Total Debt$704.4M
Retained Earnings$14.86B
Shareholder Equity$10.62B
Shares Outstanding575,800,000

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow$651.9M
Investing Cash Flow-$193.2M
Financing Cash Flow-$300.0K
CapEx-$66.9M
Free Cash Flow$585.0M
Depreciation & Amort.$49.3M
Stock-Based Comp$42.2M
Acquisitions / Disposals-$5.7M
Investment Activity-$113.6M
Debt Issued/Repaid$0.00
Equity Issued/Repaid-$99.5M
Dividends Paid$0.00
Net Change in Cash$462.2M
Data cached · Meta live · Daily live · Statements live · TTL 24h